Pfizer agrees to pay $93 million to settle Lipitor antitrust lawsuit
Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay sales of less expensive, generic versions of the cholesterol drug Lipitor. Attorneys for Lipitor purchasers including Rochester…#pfizer #ranbaxylaboratories #puertorico #drogueriabetances #llc #trenton #newjersey #ranbaxy #sunpharma #shamlitigation
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Atorvastatin Calcium | Cholesterol | Health | India Health | Lawsuits | Legislation | Lipitor | Pfizer | Statin Therapy | Zivast